Savior LLC Amgen Inc Transaction History

Savior LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 03, 2022	SELL	$198.88 - $227.6 $4,375 - $5,007	-22 Closed	0 $0
Q3 2021 Oct 05, 2021	SELL	$212.27 - $248.7 $10,825 - $12,683	-51 Reduced 69.86%	22 $5,000
Q4 2020 Feb 02, 2021	SELL	$216.38 - $257.67 $4,543 - $5,411	-21 Reduced 22.34%	73 $17,000
Q2 2020 Jul 28, 2020	BUY	$197.81 - $242.74 $4,351 - $5,340	22 Added 30.56%	94 $22,000
Q1 2020 Apr 22, 2020	SELL	$182.24 - $241.7 $12,210 - $16,193	-67 Reduced 48.2%	72 $15,000
Q4 2019 Jan 22, 2020	BUY	$189.21 - $243.2 $26,300 - $33,804	139 New	139 $34,000

3,122

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Savior LLC, based on Form 13F filings with the SEC.

Stay updated on Savior LLC with notifications on news.